Status:

COMPLETED

University of Utah COVID-19 Hydrochloroquine Trial

Lead Sponsor:

University of Utah

Conditions:

Coronavirus Infection

Coronavirus

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

A novel coronavirus, SARS-CoV-2, is responsible for a rapidly spreading pandemic that has reached 160 countries, infecting over 500,000 individuals and killing more than 24,000 people. SARS-CoV-2 caus...

Detailed Description

Background COVID-19 is pandemic with high mortality among hospitalized patients despite a benign course in the large majority of patients infected. Limited data are available from small outpatient stu...

Eligibility Criteria

Inclusion

  • Patient age ≥18 years, competent to provide consent
  • Within 48 hours of positive nucleic acid test for SARS-CoV-2

Exclusion

  • Patient already prescribed chloroquine or hydroxychloroquine
  • Allergy to hydroxychloroquine
  • History of bone marrow or solid organ transplant
  • Known G6PD deficiency
  • Chronic hemodialysis, peritoneal dialysis, continuous renal replacement therapy or Glomerular Filtration Rate \< 20ml/min/1.73m2
  • Known liver disease (e.g. Child Pugh score ≥ B or AST\>2 times upper limit)
  • Psoriasis
  • Porphyria
  • Known cardiac conduction delay (QTc \> 500mSec) or taking any prescription medications known to prolong QT interval
  • Concomitant use of digitalis, flecainide, amiodarone, procainamide, or propafenone
  • Seizure disorder
  • Prisoner
  • Weight \< 35kg
  • Inability to follow-up - no cell phone or no address or not Spanish or English speaking
  • Receipt of any experimental treatment for SARS-CoV-2 (off-label, compassionate use, or trial related) within the 30 days prior to the time of the screening evaluation
  • Patient or another member of patient's household has been already enrolled in this study.

Key Trial Info

Start Date :

April 4 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 15 2021

Estimated Enrollment :

368 Patients enrolled

Trial Details

Trial ID

NCT04342169

Start Date

April 4 2020

End Date

November 15 2021

Last Update

February 15 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah

Salt Lake City, Utah, United States, 84108